 
            
    
    
  
R&D outlays and patents alone don’t effectively measure corporate creativity
 
            
    
    
  
Field researchers constructed a model to subsidize essential goods for low-income communities in crisis, and profit in recovery
 
            
    
    
  
Sales forecasting improves markedly as firms participate in standard setting organizations
 
            
    
    
  
Backers like to offer suggestions to a not-quite-finished product
 
            
    
    
  
Pharma companies less likely to disclose critical drug information than public institutions
 
            
    
    
  
New product filings to FDA included stronger safety features and larger technological advances
 
            
    
    
  
Dedicated FDA staff guide companies during design of clinical trials
 
            
    
    
  
Researchers aim to help the agency, drug companies and patients better understand the complex authorization process